ZSAN - Zosano Pharma Corporation

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue--3132,861
Cost of Revenue20,18820,45720,36610,887
Gross Profit-20,188-20,457-20,053-8,026
Operating Expenses
Research Development----
Selling General and Administrative8,1828,1766,3154,420
Non Recurring----
Total Operating Expenses28,37028,63326,68115,307
Operating Income or Loss-28,370-28,633-26,368-12,446
Income from Continuing Operations
Total Other Income/Expenses Net-735-1,199-2,059-1,795
Earnings Before Interest and Taxes-28,370-28,633-26,368-12,446
Interest Expense-742-1,192-1,564-1,848
Income Before Tax-29,105-29,832-28,427-14,241
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-29,105-29,832-28,427-14,241
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-29,105-29,832-28,427-14,241
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-29,105-29,832-28,427-14,241